ReviewJournal of hospice and palliative care2026
Application of Digital Technology in Palliative Care in Japan.
Review in Journal of hospice and palliative care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To provide a comprehensive overview of the use of digital technology in palliative care, focusing on its potential and challenges. Methods: A narrative review of recent literature and clinical applications in Japan was conducted by examining smartphone applications, extended reality (XR), electronic patient-reported outcomes (ePRO), non-wearable sensors, and artificial intelligence. Results: Smartphone applications provide continuous psychological support and alleviate loneliness. XR (mainly virtual reality) offers distraction therapy for symptom relief and fulfills patients' "last wishes." ePRO systems and non-wearable bed sensors enable proactive care through real-time symptom and agitation monitoring. AI assists in predicting non-visible symptoms and formulating personalized care plans. Despite these benefits, challenges such as the digital divide, ethical and legal concerns, and the need for high-quality evidence remain. Conclusion: Digital technologies can significantly enhance non-pharmacological interventions in palliative care. Realizing "personalized digital palliative care" requires the integration of these tools according to individual patient needs, along with the resolution of ethical and technical issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.